Yvonne Lo - Concepedia

Concepedia

Author

Yvonne Lo

Incyte (United States)

Also Known As

Y. Y. C. Lo, Y.Y.C. Lo, Yvonne Lo, Yvonne Y C Lo, Yvonne Y. C. Lo, Yvonne Y. Lo, Yvonne Y.C. Lo, Yvonne YC Lo

43

Publications

3.7K

Citations

22

H-Index

67

Concepts

All Affiliations

Incyte (United States)University of Hong Kong Chinese University of Hong Kong Mount Sinai Hospital University of Toronto

YL

About

Yvonne Lo is an author at Incyte (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Cell Biology	4	4	914
3	Public Health	2	2	123
4	Diabetes	2	2	123
5	Health Sciences	1	1	30

Yvonne Lo

×

30

Publications

3.7K

Citations

22

H-Index

	Year	Citations
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu, Blood	2010	813
Involvement of Reactive Oxygen Species in Cytokine and Growth Factor Induction of c-fos Expression in Chondrocytes Yvonne Lo, Tony F. Cruz Journal of Biological Chemistry	1995	536
Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH2-terminal Kinases Yvonne Lo, Johnson M. S. Wong, Tony F. Cruz Journal of Biological Chemistry Lipid PeroxidationImmunologyPathologyRedox BiologyOxidative Stress	1996	496
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer Bin-Bing Zhou, Michael Peyton, Biao He, Cancer Cell Tumor BiologyAdam-mediated Ligand CleavageEgfr PathwaysMedicineBronchial Neoplasm	2006	375
The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers Jack Shi, Xuejun Chen, Fiona Lee, The Journal of Clinical Pharmacology ImmunologyPharmacotherapyInflammatory ArthritisTranslational PharmacologyPre-clinical Pharmacology	2014	223
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers Jack Shi, Xuejun Chen, Ryan McGee, The Journal of Clinical Pharmacology Jak EnzymesIncb018424 PhosphateMedicineHealthy VolunteersToxicology	2011	164
Interleukin-1β induction of c-fos and collagenase expression in articular chondrocytes: Involvement of reactive oxygen species Yvonne Lo, Julie Conquer, S Grinstein, Journal of Cellular Biochemistry	1998	156
Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer Jordan S. Fridman, Eian Caulder, Michael Hansbury, Clinical Cancer Research	2007	143
The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers Jack Shi, Xuejun Chen, Thomas Emm, The Journal of Clinical Pharmacology Incb018424 PhosphateChemoprevention StrategyImmunologyWhole BloodPharmacotherapy	2011	111
A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: A pilot single-blinded randomized controlled trial Carlos King Ho Wong, Colman Siu Cheung Fung, Samuel C. Siu, Diabetes Research and Clinical Practice Family MedicineDiabetes ManagementHealth PolicyMedicineHealth Communication	2013	83

Page 1